Why use Inato
How it works
For Research Sites
Why use Inato
How it works
Volunteer to Share
Inato's Enrollment Plan
Discover how Inato's unique trial application transforms the site selection experience and uncovers the crucial information sponsors need to select the right sites for their trial.
Inato's Inclusive Research Program
In recent history, we've made some incredible medical innovations through trials. But not everyone has access. Let's change that. Throughout the world, if you fall within a minority or otherwise marginalized group, it's not only more likely that you won't have access to clinical trial research but also that a breakthrough drug hasn't been adequately tested on people of your ethnicity or background. Sponsors want their trials to be inclusive because it leads to more robust analysis, faster drug approvals, and improved patient outcomes. However, it's not always easy to engage underserved patients in research. That's where community sites come in. By partnering with investigators who already have trusted relationships with patients and deep ties to the community, sponsors can reach untapped patient populations. **Inato's Inclusive Research Program connects sponsors with proven-diverse sites, making sure the latest medical innovations are safe and effective for everyone.**
Introducing the Inato Verified Commitment
Today, sponsors have little visibility into the process sites use to create enrollment estimates. We can fix that. For sponsors, the current process means two sites committing to the same number of patients could prove to have wildly different results. So how do you know which one to select? Take the guess work out of planning with the Inato Verified Commitment. Our team conducts a probability analysis to determine the likelihood that a site can enroll a given number of patients and only awards a verified commitment when we are at least 80% confident that the site will reach their goals. Download our one-pager to learn more about increasing the predictability of your next trial.
Overview: Inato for Sites
Explore how Inato works for sites and what other site users are saying.
Case Study: Phase III PTSD
A top global sponsor was experiencing significant delays in their trial timelines for two sister PTSD studies. Coupled with a high screen failure rate holding back progress, the stringent eligibility criteria complicated their approach in identifying sites with access to the right patient population. Looking to overcome these barriers and find motivated sites with a proven ability to access PTSD patients, the sponsor chose to partner with Inato.